<DOC>
	<DOCNO>NCT02801071</DOCNO>
	<brief_summary>The purpose study show intake L-citrulline improves muscle function patient Post-Polio Syndrome .</brief_summary>
	<brief_title>L-Citrulline Patients With Post-Polio Syndrome</brief_title>
	<detailed_description>This single center , randomize , double-blind , placebo control study . The study medication consist L-citrulline , respectively placebo give orally ; 5 g L-citrulline placebo give three time daily . The duration study 48 week comprehend one screen four study visit .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Postpoliomyelitis Syndrome</mesh_term>
	<criteria>Prior paralytic poliomyelitis evidence motor neuron loss A period partial complete functional recovery acute paralytic Poliomyelitis Slowly progressive persistent new muscle weakness decrease endurance , without generalize fatigue , muscle atrophy , muscle joint pain . Symptoms persist least year Exclusion neuromuscular , medical skeletal abnormality cause symptoms Patients older 18 year time Screening ambulant ability walk 150m 6 min . Walking distance ( 6MWD ) female childbearing potential willing use contraceptive study Previous ( 3 month less ) concomitant participation therapeutic trial Use Lcitrulline Larginine within last 3 month Known individual hypersensitivity Lcitrulline Known suspect malignancy Other chronic disease clinical relevant limitation renal , liver , heart function accord discretion investigator Pregnant breastfeed woman Severe renal failure ( calculate GFR &lt; 30 ml/min )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Post-Polio Syndrome</keyword>
	<keyword>PPS</keyword>
</DOC>